Altimmune (STU:3G0) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:3G0 Altimmune Inc STU:3G0
34 GF Score
Price €2.46
! 2 Warning Signs
View Full Analysis

What is Altimmune Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:3G0 vs RGNX, TRAX, ASMB: Short Interest Comparison

For the Biotechnology subindustry, Altimmune's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altimmune Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altimmune's Short Interest distribution charts can be found below:

* The bar in red indicates where Altimmune's Short Interest falls into.


STU:3G0
34GF Score
Altimmune Inc STU:3G0
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Altimmune Business Description

Other Exchanges ALT:USAALT1:Mexico0A4C:UK
Address 910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
34GF Score

Get the complete analysis for STU:3G0

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.46
Price